BeOne Medicines (ONC) Non-Current Assets (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Non-Current Assets data on file, last reported at $2.0 billion in Q1 2026.

• Quarterly Non-Current Assets changed 0.38% year-over-year to $2.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 billion (changed 0.38% YoY) and the FY2025 annual result came in at $2.0 billion, up 1.33% from the prior year.
• Non-Current Assets steadied at $2.0 billion in Q1 2026 per ONC's latest filing, from $2.0 billion in the prior quarter.
• Across five years, Non-Current Assets topped out at $2.0 billion in Q2 2025 and bottomed at $976.8 million in Q3 2022.
• The 5-year median for Non-Current Assets is $1.8 billion (2024), against an average of $1.6 billion.
• The widest annual swing landed in 2022, when Non-Current Assets soared 57.82%; it then gained 0.38% in 2026.
• Tracing ONC's Non-Current Assets over 5 years: stood at $1.2 billion in 2022, then jumped by 36.65% to $1.6 billion in 2023, then rose by 20.44% to $1.9 billion in 2024, then climbed by 1.33% to $2.0 billion in 2025, then decreased by 0.14% to $2.0 billion in 2026.
• Per Business Quant, the three latest ONC Non-Current Assets figures stand at $2.0 billion (Q1 2026), $2.0 billion (Q4 2025), and $2.0 billion (Q3 2025).

Peer Comparison